(Vienna, 09.09.2020) Scientists at St. Anna Children's Cancer Research Institute provide an important new insight in neuroblastoma, the most common solid tumor in infants and young children: the influence of genome alterations on the course…
Childhood Cancer Neuroblastoma: Not only DNA, it´s also the age that matters
Cure Childhood Cancer? Challenge accepted, says Prof. Heinrich Kovar
(Vienna, 07.09.2020) Prof. Heinrich Kovar PhD, heads the Molecular Biology of Solid Tumors group at St. Anna Children's Cancer Research Institute. He was one of the Institute’s founders and its scientific director for 17 years.…
Childhood Cancer Awareness Month: „We want to give children with cancer a chance.“
(Vienna, 01.09.2020) Childhood cancer scientists are creative minds who have one big goal: Saving lives. We asked scientists at St. Anna Children's Cancer Research Institute (CCRI) how this could be achieved even better in the…
Science that makes a difference: „Because I love, what I do”
(01.09.2020) Dr. Eleni M. Tomazou, PhD, heads the research group "Epigenome-based precision medicine" at the St. Anna Children's Cancer Research Institute. On the occasion of the Childhood Cancer Awareness Month September, she talks about what…
CAR-T-Cell-Immunotherapy: Teaching the CAR to steer and brake
(Vienna, 20.08.2020) In the Christian Doppler Laboratory for Next Generation CAR T Cells, another important step towards improved cancer therapy has been achieved. Scientists from the St. Anna Children's Cancer Research Institute and the University…
Surgical tumor excision increases survival rate in high-risk childhood cancer
In a worldwide cooperation, scientists of the St. Anna Children's Cancer Research Institute (CCRI) and St. Anna Children´s Hospital have gained new insights into how to increase the survival rate in the high-risk form of…
When immune cells aren’t in their senses: a key regulator of the actin cytoskeleton ensures signal perception and prevents autoimmunity
One of the human immune system’s most important and impressive features is its ability to reliably distinguish self from non-self. Invading pathogens, infected or malignant cells have to be eliminated while protecting healthy cells. To…
#MissionCancer – CCRI´s international cooperation projects as a key to success
Federal Minister Karoline Edtstadler and Federal Minister Prof. Dr. Heinz Faßmann met with CCRI experts in order to exchange views on the topic of "Europe-wide research projects" against the background of the Future Conference to…
A conformation-specific ON-switch for controlling CAR T cells with an orally available drug
New publication from our Christian Doppler Laboratory for Next Generation CAR T Cells: Brey CU., M. Dobersberger, I. Schaffner, G. Mlynek, D. Pühringer, B. Salzer, K. Djinović-Carugo, C. Obinger, W. Holter, MW. Traxlmayr & M.…
Refined Prognosis and Relapse Detection in Childhood Cancer
Liquid Biopsy, a method that has been further developed at St. Anna Children's Cancer Research Institute (CCRI) with international partners, enables a close monitoring of the tumour and allows the detection of a relapse before…